Prostate Delineation: High Quality Volume CT

Not Applicable

Completed

• Conditions: Prostate Cancer
• Interventions: Other: High Quality Volume CT Scan; MRI Scan

• Registration Number: NCT01878773
• Lead Sponsor: University Health Network, Toronto

Brief Summary

This study will look at how feasible it is to use a certain type of Computed Tomography (CT) to scan prostate cancer, called a high quality volume CT scan. It is hoped that this technique will help doctors provide a higher-quality image of the prostate cancer, making it easier to plan the area that will be treated. Using this type of CT scan will also lessen the amount of time patients spend in the scanner.

This study will not offer patients a different treatment for their prostate cancer. Patients will receive the most appropriate standard treatment whether or not they are in this study.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-10
• Study First Submitted: 2012-10-24
• Study First Submitted QC: 2013-06-12
• Study First Posted: 2013-06-17
• Status Verified: 2017-08
• Primary Completion: 2017-08-11
• Study Completion: 2017-08-11
• Last Update Submitted: 2017-08-18
• Last Update Posted: 2017-08-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 10

Inclusion Criteria

1. At least 18 years old
2. Subjects undergoing radical external beam radiotherapy for prostate cancer
3. Ability to provide written informed consent

Exclusion Criteria

1. Age ≤ 18 years
2. Subjects not suitable for MRI scanning
3. 3 usable image sets not obtained during treatment planning scans.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
High Quality Volume CT Scan; MRI Scan	High Quality Volume CT Scan; MRI Scan	Patients will have the High Quality volume CT scan immediately after their CT scan followed by MRI Scan.

Primary Outcome Measures

Name	Time	Method
Using different scanning methods for patients undergoing radical external beam radiotherapy for prostate cancer to determine inter-observer variability in prostate gland delineation on the images.	6 months

Secondary Outcome Measures

Name	Time	Method
Determine the concordance between delineators in identifying the prostate apex on the 2 CT image sets. MRI will be considered the "gold-standard" for identifying the prostate apex.	6 months

Trial Locations

Locations (1)

University Health Network, The Princess Margaret; 🇨🇦 Toronto, Ontario, Canada